The extracellular matrix in diabetic nephropathy - PubMed (original) (raw)
Review
The extracellular matrix in diabetic nephropathy
F N Ziyadeh. Am J Kidney Dis. 1993 Nov.
Free article
Abstract
In the subgroup of diabetic patients who are destined to develop the full spectrum of the clinical syndrome of diabetic nephropathy, the kidney is afflicted with a series of distinct structural lesions principally involving the extracellular matrices. Diabetic nephropathy is characterized by hypertrophy of both glomerular and tubular elements, progressive accumulation of extracellular matrix components in the glomerular mesangium, and thickening of the glomerular and tubular basement membranes. Albeit less well recognized, progressive tubulointerstitial fibrosis is also a feature of the syndrome. Irrespective of pathogenetic mechanisms (be they metabolic, hemodynamic, or genetic), the structural changes involving the renal extracellular matrix compartments are believed to be the basis for the appearance of overt dysfunction, namely, proteinuria, hypertension, and renal failure. Therefore, a full understanding of the mechanisms that culminate in irreversible kidney failure requires a closer inspection of the status of the extracellular matrix in diabetes. This review outlines the different structural changes that typically occur during the course of the disease. Both glomerular and tubulointerstitial changes are reviewed. Valuable structural-functional correlations have been derived from examining kidney specimens obtained from patients with a wide spectrum of disease stages. Experimental animal models, supplanted with recent investigations in tissue culture on the effect of high ambient glucose levels, have increased our understanding of the cellular mechanisms that underlie the disordered matrix composition. Alterations in the metabolism of the collagens, proteoglycans, and other matrix constituents are reviewed.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
- Role of glomerular ultrafiltration of growth factors in progressive interstitial fibrosis in diabetic nephropathy.
Wang SN, LaPage J, Hirschberg R. Wang SN, et al. Kidney Int. 2000 Mar;57(3):1002-14. doi: 10.1046/j.1523-1755.2000.00928.x. Kidney Int. 2000. PMID: 10720953 - The key role of the transforming growth factor-beta system in the pathogenesis of diabetic nephropathy.
Chen S, Hong SW, Iglesias-de la Cruz MC, Isono M, Casaretto A, Ziyadeh FN. Chen S, et al. Ren Fail. 2001 May-Jul;23(3-4):471-81. doi: 10.1081/jdi-100104730. Ren Fail. 2001. PMID: 11499562 Review. - Renal tubular basement membrane and collagen type IV in diabetes mellitus.
Ziyadeh FN. Ziyadeh FN. Kidney Int. 1993 Jan;43(1):114-20. doi: 10.1038/ki.1993.19. Kidney Int. 1993. PMID: 8433550 Review. - Extracellular matrix in human diabetic nephropathy: reduced expression of heparan sulphate in skin basement membrane.
van der Pijl JW, Daha MR, van den Born J, Verhagen NA, Lemkes HH, Bucala R, Berden JH, Zwinderman AH, Bruijn JA, van Es LA, van der Woude FJ. van der Pijl JW, et al. Diabetologia. 1998 Jul;41(7):791-8. doi: 10.1007/s001250050989. Diabetologia. 1998. PMID: 9686920 - Nodular lesions and mesangiolysis in diabetic nephropathy.
Wada T, Shimizu M, Yokoyama H, Iwata Y, Sakai Y, Kaneko S, Furuichi K. Wada T, et al. Clin Exp Nephrol. 2013 Feb;17(1):3-9. doi: 10.1007/s10157-012-0711-6. Epub 2012 Oct 26. Clin Exp Nephrol. 2013. PMID: 23100177 Review.
Cited by
- Complement Cascade Proteins Correlate with Fibrosis and Inflammation in Early-Stage Type 1 Diabetic Kidney Disease in the Ins2Akita Mouse Model.
Tserga A, Saulnier-Blache JS, Palamaris K, Pouloudi D, Gakiopoulou H, Zoidakis J, Schanstra JP, Vlahou A, Makridakis M. Tserga A, et al. Int J Mol Sci. 2024 Jan 23;25(3):1387. doi: 10.3390/ijms25031387. Int J Mol Sci. 2024. PMID: 38338666 Free PMC article. - LncRNA MEG3 inhibits renal fibrinoid necrosis of diabetic nephropathy via the MEG3/miR-21/ORAI1 axis.
Xu BW, Rao Y, Wang L, Chen SM, Zou SB. Xu BW, et al. Mol Biol Rep. 2023 Apr;50(4):3283-3295. doi: 10.1007/s11033-023-08254-2. Epub 2023 Jan 30. Mol Biol Rep. 2023. PMID: 36715789 - Integrated Analysis of Multiple Microarray Studies to Identify Core Gene-Expression Signatures Involved in Tubulointerstitial Injury in Diabetic Nephropathy.
Zhou H, Yang Z, Mu L, Shi Y. Zhou H, et al. Biomed Res Int. 2022 May 10;2022:9554658. doi: 10.1155/2022/9554658. eCollection 2022. Biomed Res Int. 2022. PMID: 35592524 Free PMC article. - MicroRNA-10a/b inhibit TGF-β/Smad-induced renal fibrosis by targeting TGF-β receptor 1 in diabetic kidney disease.
Li J, Yue S, Fang J, Zeng J, Chen S, Tian J, Nie S, Liu X, Ding H. Li J, et al. Mol Ther Nucleic Acids. 2022 Apr 7;28:488-499. doi: 10.1016/j.omtn.2022.04.002. eCollection 2022 Jun 14. Mol Ther Nucleic Acids. 2022. PMID: 35505968 Free PMC article. - Diabetic Kidney Disease, Endothelial Damage, and Podocyte-Endothelial Crosstalk.
Gil CL, Hooker E, Larrivée B. Gil CL, et al. Kidney Med. 2020 Dec 7;3(1):105-115. doi: 10.1016/j.xkme.2020.10.005. eCollection 2021 Jan-Feb. Kidney Med. 2020. PMID: 33604542 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical